Upstart Holdings, Inc.
UPST Nasdaq Finance Services Financials FY2019–FY2025
Last close · Oct 23, 2026
$23.78
0.3%What Upstart Holdings, Inc. does
No business description yet.
- Legal name
- Upstart Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 10, 2026
- Accession · CIK
- 0001647639-26-000027
0001647639
Revenue and margins
Upstart Holdings, Inc. had $1.0B of revenue in fiscal 2025, up 64.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$148M in fiscal 2025, −14.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Upstart Holdings, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 20.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Upstart Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.2B | $532M | $368M | $788M | $652M |
| Interest coverage | 43.0x | −10.5x | −7.4x | — | — |
| Total assets | $1.8B | $1.9B | $2.0B | $2.4B | $3.0B |
| Total liabilities | $1.0B | $1.3B | $1.4B | $1.7B | $2.2B |
| Shareholders' equity | $807M | $672M | $635M | $633M | $799M |
| Net debt (− = net cash) | — | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ |
| Return on assets rose | — | — | ✓ | ✕ | ✕ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — | — | — | — | — |
| Current ratio rose | — | — | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✕ | ✕ | ✕ | ✓ | ✓ |
| F-score | — / 3 | — / 4 | — / 6 | — / 6 | — / 6 | — / 6 | — / 6 |
| Accruals ratio | — | −2.0% | −2.9% | 29.2% | −6.5% | −14.4% | 7.5% |
| Altman Z'' | — | — | — | — | — | — | — |
7 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $164M | $233M | $849M | $842M | $514M | $637M | $1.0B |
| Net interest income | — | — | $47.3M | −$64.8M | −$46.9M | $1.1M | $93.8M |
| Research and development | $18.8M | $38.8M | $134M | $237M | $280M | $254M | $258M |
| Operating income | −$4.6M | $11.8M | $141M | −$114M | −$257M | −$173M | $42.6M |
| Interest expense | $26.5M | $8.0M | $3.3M | $10.8M | $34.9M | — | — |
| Pretax income | −$4.9M | $6.0M | $134M | −$109M | −$240M | −$128M | $54.3M |
| Income tax | $0.1M | $0.4M | −$1.7M | −$0.4M | $0.1M | $0.2M | $0.7M |
| Net income | −$0.5M | $6.0M | $135M | −$109M | −$240M | −$129M | $53.6M |
| Net income to common | −$0.5M | $0.0M | $135M | −$109M | −$240M | −$129M | $53.6M |
| Diluted EPS | −$0.03 | $0.00 | $1.43 | −$1.31 | −$2.87 | −$1.44 | $0.45 |
| Diluted shares | 0.01B | 0.02B | 0.09B | 0.08B | 0.08B | 0.09B | 0.11B |
| Cash flow | |||||||
| Cash from operations | $31.6M | $15.7M | $168M | −$658M | −$112M | $186M | −$148M |
| Capital expenditure | $4.0M | $1.4M | $8.4M | $8.8M | $1.5M | $0.8M | $0.3M |
| Free cash flow | $27.6M | $14.3M | $160M | −$667M | −$113M | $185M | −$148M |
| Depreciation and amortization | $0.8M | $2.3M | $7.5M | $13.5M | $24.9M | $20.5M | $24.8M |
| Stock-based compensation | $3.8M | $11.5M | $73.2M | $126M | $175M | $133M | $132M |
| Acquisitions | $0.0M | $0.0M | $16.8M | $0.0M | $0.0M | — | — |
| Share buybacks | — | — | $0.0M | $178M | $0.0M | $0.0M | — |
| Dividends and buybacks | — | — | $0.0M | $178M | $0.0M | $0.0M | — |
| Balance sheet | |||||||
| Cash and short-term investments | $80.1M | $311M | $1.2B | $532M | $368M | $788M | $652M |
| Finance lease liabilities | — | — | — | $0.0M | $0.0M | — | — |
| Property and equipment, net | — | $10.0M | $24.3M | $44.2M | $42.7M | $39.0M | $44.2M |
| Goodwill | — | $0.0M | $67.1M | $67.1M | $67.1M | $67.1M | $67.1M |
| Intangible assets | — | $0.0M | $19.9M | $15.6M | $11.4M | $9.4M | $8.3M |
| Total assets | — | $477M | $1.8B | $1.9B | $2.0B | $2.4B | $3.0B |
| Total liabilities | — | $177M | $1.0B | $1.3B | $1.4B | $1.7B | $2.2B |
| Shareholders' equity | −$61.7M | $300M | $807M | $672M | $635M | $633M | $799M |
| Margins | |||||||
| Operating margin | −2.8% | 5.0% | 16.6% | −13.5% | −50.0% | −27.2% | 4.1% |
| EBITDA margin | −2.3% | 6.0% | 17.5% | −11.9% | −45.1% | −23.9% | 6.5% |
| Net margin | −0.3% | 2.6% | 16.0% | −12.9% | −46.8% | −20.2% | 5.1% |
| FCF margin | 16.8% | 6.1% | 18.8% | −79.1% | −22.0% | 29.1% | −14.2% |
| Net interest share of revenue | — | — | 5.6% | −7.7% | −9.1% | 0.2% | 9.0% |
| Returns | |||||||
| Return on equity | — | 5.0% | 24.5% | −14.7% | −36.7% | −20.3% | 7.5% |
| Return on assets | — | 1.3% | 11.8% | −5.8% | −12.1% | −5.9% | 2.0% |
| Return on tangible equity | — | 0.0% | 18.8% | −18.4% | −43.1% | −23.1% | 7.4% |
| Growth | |||||||
| Revenue growth | — | 42.2% | 263.6% | −0.7% | −39.0% | 23.9% | 64.0% |
| Net income growth | — | — | 2,163.8% | −180.2% | — | — | — |
| EPS growth | — | — | — | −191.6% | — | — | — |
| FCF growth | — | −48.0% | 1,015.1% | −516.9% | — | — | −179.8% |
| Share count change | — | 22.2% | 441.1% | −12.7% | 1.2% | 6.8% | 20.2% |
| Financial health | |||||||
| Interest coverage | −0.2x | 1.5x | 43.0x | −10.5x | −7.4x | — | — |
| Capital allocation | |||||||
| Capex / revenue | 2.4% | 0.6% | 1.0% | 1.0% | 0.3% | 0.1% | 0.0% |
| Stock comp / revenue | 2.3% | 4.9% | 8.6% | 15.0% | 34.1% | 21.0% | 12.6% |
| Payouts / FCF | — | — | 0.0% | — | — | 0.0% | — |
| Quality scores | |||||||
| Accruals ratio | — | −2.0% | −2.9% | 29.2% | −6.5% | −14.4% | 7.5% |
Source: SEC EDGAR XBRL filings (CIK 0001647639). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
